<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Ther Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Ther Sci</journal-id><journal-id journal-id-type="publisher-id">JPTS</journal-id><journal-title-group><journal-title>Journal of Physical Therapy Science</journal-title></journal-title-group><issn pub-type="ppub">0915-5287</issn><issn pub-type="epub">2187-5626</issn><publisher><publisher-name>The Society of Physical Therapy Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25729161</article-id><article-id pub-id-type="pmc">4339131</article-id><article-id pub-id-type="publisher-id">jpts-2014-372</article-id><article-id pub-id-type="doi">10.1589/jpts.27.325</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Electrically stimulated ventilation feedback improves the ventilation pattern
in patients with COPD</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ito</surname><given-names>Kenichi</given-names></name><degrees>PT, PhD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nozoe</surname><given-names>Tatsuo</given-names></name><degrees>PT</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Okuda</surname><given-names>Miyuki</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nonaka</surname><given-names>Koji</given-names></name><degrees>PT, PhD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yamahara</surname><given-names>Jun</given-names></name><degrees>PT, MSc</degrees><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Horie</surname><given-names>Jun</given-names></name><degrees>PT, PhD</degrees><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hayama</surname><given-names>Yuka</given-names></name><degrees>Ns, PhD</degrees><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kawamura</surname><given-names>Hirobumi</given-names></name><degrees>PT, PhD</degrees><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><aff id="aff1"><label>1)</label> Graduate School of Comprehensive Rehabilitation, Osaka
Prefecture University, Japan</aff><aff id="aff2"><label>2)</label> Department of Rehabilitation Medicine, Hospital,
Anti-Tuberculosis Association, Osaka Branch, Japan</aff><aff id="aff3"><label>3)</label> Department of Internal Medicine, Hospital,
Anti-Tuberculosis Association, Japan</aff><aff id="aff4"><label>4)</label> Department of Rehabilitation Medicine, National Hospital
Organization, Osaka Minami Medical Center, Japan</aff><aff id="aff5"><label>5)</label> Faculty of Health Sciences, Kyoto Tachibana University,
Japan</aff><aff id="aff6"><label>6)</label> Faculty of Nursing, Baika Women&#x02019;s University, Japan</aff><aff id="aff7"><label>7)</label> Faculty of Nursing and Rehabilitation, Konan Women&#x02019;s
University, Japan</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Kenichi Ito, Graduate School of Comprehensive Rehabilitation, Osaka
Prefecture University: 3-7-30 Habikino, Habikino-shi, Osaka 583-8555, Japan. (E-mail: <email xlink:href="itok@rehab.osakafu-u.ac.jp">itok@rehab.osakafu-u.ac.jp</email>)</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>2</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2015</year></pub-date><volume>27</volume><issue>2</issue><fpage>325</fpage><lpage>330</lpage><history><date date-type="received"><day>12</day><month>6</month><year>2014</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2014</year></date></history><permissions><copyright-statement>2015&#x000a9;by the Society of Physical Therapy Science</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>[Purpose] We aimed to determine the effects of ventilation feedback using electrical
stimulation on ventilation pattern during exercise in patients with chronic obstructive
pulmonary disease (COPD), and develop new rehabilitation methods. [Subjects] This
randomized double-blind placebo-controlled trial included 24 patients with COPD. [Methods]
Phasic electrical stimulation during expiration (PESE) or a placebo was given to all the
cases. Minute ventilation (VE), tidal volume (TV), respiratory rate (RR), expiratory time
(Te), total respiratory time (Ttot), dead-space gas volume to tidal gas volume (VD/VT),
oxygen uptake (VO<sub>2</sub>), carbon dioxide output (VCO<sub>2</sub>), Borg scale
(Borg), and percutaneous oxygen saturation (SpO<sub>2</sub>) during rest and exercise were
assessed. [Results] The placebo group showed no obvious change in ventilation measurements
at rest or during exercise. However, in the PESE group, TV, Te, and Ttot significantly
increased, while RR and VD/VT significantly decreased during exercise compared with the
baseline measurements. Borg scores, SpO<sub>2</sub>, VO<sub>2</sub>, or VCO<sub>2</sub>
did not differ significantly. [Conclusion] PESE improves the ventilation pattern during
rest and exercise. Furthermore, PESE does not increase VO<sub>2</sub>, which may indicate
an increased workload. Biofeedback may contribute to PESE effects. Stimulation applied
during expiration may evoke sensations increasing prolonged expiration awareness,
facilitating prolongation.</p></abstract><kwd-group><title>Key words</title><kwd>Chronic obstructive pulmonary disease</kwd><kwd>Electrical stimulation</kwd><kwd>Ventilation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Exercise therapy is at the core of rehabilitation for chronic obstructive pulmonary disease
(COPD)<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref><sup>)</sup>, the incidence of which
continues to increase worldwide<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref><sup>)</sup>. Both endurance and
strength training focusing on the lower limbs can decrease the lactic acid concentration in
the blood, carbon dioxide production, and minute ventilation. The effects of exercise
therapy can subsequently decrease respiratory muscle work and improve exercise tolerance in
patients with COPD<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>.</p><p>In contrast, rapid shallow breathing is a cause of breathlessness during activities of
daily living (ADLs) and walking in patients with COPD. Therefore, decreasing the respiratory
rate and increasing the tidal volume during movement may help to decrease breathlessness in
patients with COPD. Pursed-lip breathing, which involves measuring the increase in duration
of the expiratory phase by pursing the lips and applying positive pressure during
expiration, is a breathing technique that improves ventilation efficiency in patients with
COPD<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref><sup>)</sup>. Most hospital-based programs for patients with mild-to-moderate
COPD are developed with exercise therapy and breathing techniques. Therapists instruct
patients to perform PLB both at rest and during exercise, although few patients with COPD
can maintain this breathing technique throughout exercise therapy sessions. In addition, it
is difficult for therapists to both monitor patients during exercise therapy and give
feedback on their respiratory status. We believe that reliably performing PLB during
exercise therapy decreases dyspnea, and may improve the outcome of exercise therapy.</p><p>While studying ventilation during exercise, Collins et al. created a ventilation feedback
device that provided visual and auditory feedback to subjects. They reported that
ventilatory function improved during treadmill exercise with an ergometer when patients with
COPD received ventilation feedback from the device<xref rid="r10" ref-type="bibr">10</xref>,
<xref rid="r11" ref-type="bibr">11</xref><sup>)</sup>. However, their method used a large
monitor and could be used only at specific locations; therefore, it was unsuitable for use
during ADLs or walking. We sought a similar feedback method that is portable and easily used
in various rehabilitation programs, and subsequently came across the technique of electrical
stimulation. A large number of small, portable, electrical stimulation devices ideal for our
purpose are commercially available. Moreover, Kita et al. reported that feedback through
electrical stimulation was effective in stroke rehabilitation programs<xref rid="r12" ref-type="bibr">12</xref><sup>)</sup>; electrical stimulation has been used recently in patients
with COPD for lower limb strength training<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref><sup>)</sup>.
If electrical stimulation can be used for ventilation feedback, then such a method may help
overcome the limitation of the study by Collins et al. Therefore, we created an electrical
stimulation device that provides feedback on expiration. This feedback method could improve
ventilation in COPD patients during exercise and serve as a useful exercise therapy tool.
The present study involved basic research investigating whether ventilation feedback
delivered through electrical stimulation could improve the ventilation pattern in patients
with COPD during exercise in order to develop a new method of rehabilitation.</p></sec><sec sec-type="methods" id="s2"><title>SUBJECTS AND METHODS</title><p>The subjects included 24 patients with COPD who volunteered for the study, and whose
participation was approved by their attending physician. Subjects were found through
volunteer recruitment posters displayed within hospitals; those with musculoskeletal
disease, central nervous system injury or disease, communication disorders, or severe
cardiovascular disease were excluded.</p><p>The Ethical Review Board of the Osaka Prefecture University Faculty of Comprehensive
Rehabilitation approved this study (2010P10). The content of this study was explained to
participants both orally and in writing, and their written informed consent was obtained
according to the Declaration of Helsinki.</p><p>This study was a randomized double-blind trial in which the subjects and a measurer were
randomly assigned to either the phasic electrical stimulation during expiration (PESE) group
or the placebo group using a random number table.</p><p>The protocol included 5&#x02005;min of rest followed by 5&#x02005;min of exercise. A bicycle ergometer
(STB-1400, Nihon Kohden, Tokyo, Japan) was used to measure exercise load. For both safety
and ethical considerations, the exercise intensity was set to a level that was equivalent to
the subject&#x02019;s daily walking routine, which was between 20% and 30% of the predicted maximal
heart rate (Karvonen Formula). A respiratory metabolism measuring apparatus (Aeromonitor
AE-300S, Minato Medical Science, Osaka, Japan) was used to measure respiratory metabolism at
rest and during exercise. Minute ventilation (VE), tidal volume (TV), respiratory rate (RR),
expiratory time (Te), total respiratory time (Ttot), dead-space gas volume to tidal gas
volume (VD/VT), end-tidal CO<sub>2</sub> (ETCO<sub>2</sub>), oxygen uptake (VO<sub>2</sub>),
and carbon dioxide output (VCO<sub>2</sub>) were measured. Perceived exertion was measured
using the Borg scale, and percutaneous oxygen saturation (SpO<sub>2</sub>) was measured
using a pulse oximeter (PULSOX-300i, Konica Minolta, Tokyo, Japan). The protocol was
performed twice for both groups, before and during exercise, followed by data sampling.</p><p>We used a portable, commercially available low-frequency electrical stimulation device
(remodeled Trio 300; Ito Co., Ltd., Tokyo, Japan) in this study. The device has a pressure
transducer system attached to a nasal cannula, which senses the exhalation of air by the
patient. The device applies electrical stimulation during expiration, and is fitted with an
external input terminal. The nasal cannula/pressure transducer was connected to a control
unit that converted the pressure transducer signal into an electrical signal. This signal
was subsequently fed into the stimulator&#x02019;s external input terminal, triggering electrical
stimulation. Stimulation was delivered bilaterally near the abdominal muscles (expiratory
muscles) of the subjects. Electrodes were placed approximately 2&#x02005;cm from the umbilical
region, with the cathodes attached bilaterally and symmetrically around the midline, and the
anodes placed 1&#x02005;cm above each cathode. Taking into account ethical aspects regarding the
possibility of pain resulting from electrical stimulation, electrical stimulation was
delivered with a pulse width of 200 &#x003bc;s and at 70% of the current intensity (Ah) at which
pain was felt and no muscle contractions occurred.</p><p>In the PESE group, stimulation was delivered at a frequency of 20&#x02005;Hz and the duration of
stimulation was equal to that of expiration, whereas the duration of rest was equal to that
of inspiration. In addition, the subjects were given the following oral instructions once
prior to the test: &#x0201c;Electrical stimulation will continue as long as you exhale, so make a
conscious effort to exhale such that the electrical stimulation is maintained as long as
possible and consciously perform PLB&#x0201d;.</p><p>As the control for the PESE, we included a placebo group to address bias related to
electrical stimulation. In the placebo group, weak electrical stimulation was given and
measured. In addition, the subjects were asked to perform PLB during the test. The same
protocol was used in the placebo group, except that the stimulation was delivered at a
frequency of 25&#x02005;Hz in 10-s phases with 10&#x02005;s of rest between phases. The frequency for the
placebo group was different from that for the PESE group, as the same frequency as used for
PESE was not available in the program used for regular interval stimulation. Thus, we used
25&#x02005;Hz as approximately the same frequency in this study. In addition, subjects were given
oral instructions to consciously perform PLB prior to the test.</p><p>An allocator prepared all subjects for electrical stimulation. The person taking the
measurements was unaware of the group allocations, thus ensuring blinding. Both groups
practiced PLB at the beginning of the experiment until they were proficient before
performing exercise. PLB in this study involved breathing with prolonged expiration and the
lips pursed.</p><p>On the basis of the data obtained from a pilot study, sample size was determined by the
main outcome measure, the difference in respiratory rate between the two groups, and the
difference in respiration rate was 5 breaths/min (SD, 4.3; &#x003b1;, 0.05; power, 0.80). Therefore,
we selected a sample size that included 26 individuals, with 13 in each group. We aimed to
examine 26 subjects in this study.</p><p>The SPSS version 11.0&#x02005;J (SPSS, IBM, Armonk, NY, USA) statistical software was used for the
statistical analysis. A Mann-Whitney U test was used to compare baseline measures between
the two groups, and a Wilcoxon rank-sum test was used for intergroup comparisons before and
during exercise periods. A p value of &#x0003c; 0.05 was considered statistically significant.
The allocator and researcher were different people in order to blind the allocation details
in the data analysis.</p></sec><sec sec-type="results" id="s3"><title>RESULTS</title><p><xref ref-type="fig" rid="fig_001">Figure 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Flow diagram of the study population</p></caption><graphic xlink:href="jpts-27-325-g001"/></fig> shows the overall procedure for this study. The 24 subjects were assigned to either
the placebo group (n = 12) or the PESE group (n = 12), and measurements were taken for all
subjects prior to the intervention (baseline), at rest, and during exercise. One subject in
the placebo group reported knee pain and was excluded from the analysis. Therefore, data
were analyzed from 11 subjects in the placebo group and 12 subjects in the PESE group.
Meanwhile, we selected a sample size that included 26 individuals based on the calculated
results. However, a significant difference was observed for the main outcome measure, the
difference in RR, between the two groups in the data for 24 subjects. Due to ethical
considerations, we ended data sampling at that time.</p><p><xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Participant characteristics</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Placebo group<break/>(n = 11)</th><th align="center" rowspan="1" colspan="1">PESE group<break/>(n = 12)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, y</td><td align="center" rowspan="1" colspan="1">71.0 &#x000b1; 9.7</td><td align="center" rowspan="1" colspan="1">70.9 &#x000b1; 5.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex, male/female</td><td align="center" rowspan="1" colspan="1">9 / 2</td><td align="center" rowspan="1" colspan="1">11 / 1</td></tr><tr><td align="left" rowspan="1" colspan="1">GOLD stage, No.</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">I</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">II</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">III</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">IV</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">MRC grade, No.</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">I</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">II</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">III</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">IV</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">VI</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">VC, L</td><td align="center" rowspan="1" colspan="1">3.06 &#x000b1; 0.79</td><td align="center" rowspan="1" colspan="1">2.97 &#x000b1; 0.57</td></tr><tr><td align="left" rowspan="1" colspan="1">VC, % predicted</td><td align="center" rowspan="1" colspan="1">95.9 &#x000b1; 18.2</td><td align="center" rowspan="1" colspan="1">89.1 &#x000b1; 14.7</td></tr><tr><td align="left" rowspan="1" colspan="1">FEV1, L</td><td align="center" rowspan="1" colspan="1">1.56 &#x000b1; 0.50</td><td align="center" rowspan="1" colspan="1">1.73 &#x000b1; 0.70</td></tr><tr><td align="left" rowspan="1" colspan="1">FEV1, % predicted</td><td align="center" rowspan="1" colspan="1">65.7 &#x000b1; 20.0</td><td align="center" rowspan="1" colspan="1">66.3 &#x000b1; 27.8</td></tr><tr><td align="left" rowspan="1" colspan="1">FEV1/FVC, %</td><td align="center" rowspan="1" colspan="1">52.6 &#x000b1;11.6</td><td align="center" rowspan="1" colspan="1">56.5 &#x000b1; 16.7</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">22.2 &#x000b1; 3.09</td><td align="center" rowspan="1" colspan="1">22.2 &#x000b1; 3.18</td></tr><tr><td align="left" rowspan="1" colspan="1">TP, g/dl</td><td align="center" rowspan="1" colspan="1">6.43 &#x000b1; 0.36</td><td align="center" rowspan="1" colspan="1">6.78 &#x000b1; 0.55</td></tr><tr><td align="left" rowspan="1" colspan="1">Alb, g/dl</td><td align="center" rowspan="1" colspan="1">3.87 &#x000b1; 0.20</td><td align="center" rowspan="1" colspan="1">4.01 &#x000b1; 0.45</td></tr><tr><td align="left" rowspan="1" colspan="1">6MWD, m</td><td align="center" rowspan="1" colspan="1">395 &#x000b1; 130</td><td align="center" rowspan="1" colspan="1">444 &#x000b1; 79</td></tr><tr><td align="left" rowspan="1" colspan="1">SGRQ, points</td><td align="center" rowspan="1" colspan="1">44.0 &#x000b1; 13.9</td><td align="center" rowspan="1" colspan="1">34.6 &#x000b1; 19.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Muscle strength</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">Knee extension, kg/Wt&#x000d7;100</td><td align="center" rowspan="1" colspan="1">58.1 &#x000b1; 17.0</td><td align="center" rowspan="1" colspan="1">57.0 &#x000b1; 16.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Consultation for rehabilitation, No.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15pt" rowspan="1" colspan="1">Yes/no</td><td align="center" rowspan="1" colspan="1">5 / 6</td><td align="center" rowspan="1" colspan="1">7 / 5</td></tr></tbody></table><table-wrap-foot><p>Results are presented as the mean &#x000b1; SD or %, unless otherwise indicated. 6MWD: 6-min
walking distance; GOLD: Global Initiative for Chronic Obstructive Lung Disease; MRC:
Medical Research Council; SGRQ: St. George&#x02019;s Respiratory Questionnaire; TP: total
protein</p></table-wrap-foot></table-wrap> describes the age, sex, COPD severity (Global Initiative for Chronic
Obstructive Lung Disease staging system), extent of breathlessness (Medical Research Council
dyspnea scale), lung function, nutritional status, and motor function of the subjects in
both groups. No significant differences were observed between the groups for any parameter.
<xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Baseline data of the two groups</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="3" align="left"/><th colspan="2" align="center" rowspan="1">Baseline</th></tr><tr><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Placebo<break/>(n = 11)</th><th align="center" rowspan="1" colspan="1">PESE<break/>(n = 12)</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">VE , L/min</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">10.5 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">10.2 &#x000b1; 1.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">20.2 &#x000b1; 5.1</td><td align="center" rowspan="1" colspan="1">19.9 &#x000b1; 4.4</td></tr><tr><td align="left" rowspan="2" colspan="1">TV, mL</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">799.0 &#x000b1; 321.0</td><td align="center" rowspan="1" colspan="1">730.0 &#x000b1; 172.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">1085.0 &#x000b1; 354.0</td><td align="center" rowspan="1" colspan="1">1104.0 &#x000b1; 262.0</td></tr><tr><td align="left" rowspan="2" colspan="1">RR, n/min</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">16.1 &#x000b1; 4.22</td><td align="center" rowspan="1" colspan="1">16.0 &#x000b1; 3.28</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">21.6 &#x000b1; 4.60</td><td align="center" rowspan="1" colspan="1">20.2 &#x000b1; 4.60</td></tr><tr><td align="left" rowspan="2" colspan="1">Te, s</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">2.75 &#x000b1; 1.50</td><td align="center" rowspan="1" colspan="1">2.43 &#x000b1; 0.66</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">1.91 &#x000b1; 0.74</td><td align="center" rowspan="1" colspan="1">1.92 &#x000b1; 0.58</td></tr><tr><td align="left" rowspan="2" colspan="1">Ttot, s</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">4.21 &#x000b1; 1.91</td><td align="center" rowspan="1" colspan="1">3.99 &#x000b1; 1.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">3.04 &#x000b1; 1.04</td><td align="center" rowspan="1" colspan="1">3.13 &#x000b1; 0.70</td></tr><tr><td align="left" rowspan="2" colspan="1">VD/VT</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">0.43 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">0.42 &#x000b1; 0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">0.40 &#x000b1; 0.05</td><td align="center" rowspan="1" colspan="1">0.37 &#x000b1; 0.04</td></tr><tr><td align="left" rowspan="2" colspan="1">ETCO<sub>2</sub>, %</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">4.43 &#x000b1; 0.75</td><td align="center" rowspan="1" colspan="1">4.35 &#x000b1; 0.33</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">5.08 &#x000b1; 0.87</td><td align="center" rowspan="1" colspan="1">4.89 &#x000b1; 0.53</td></tr><tr><td align="left" rowspan="2" colspan="1">Borg dyspnea, points</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">0.05 &#x000b1; 0.15</td><td align="center" rowspan="1" colspan="1">0.17 &#x000b1; 0.58</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">1.45 &#x000b1; 0.16</td><td align="center" rowspan="1" colspan="1">1.54 &#x000b1; 1.52</td></tr><tr><td align="left" rowspan="2" colspan="1">SpO<sub>2</sub>, %</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">95.9 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">96.0 &#x000b1; 1.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">92.5 &#x000b1; 4.0</td><td align="center" rowspan="1" colspan="1">93.8 &#x000b1; 2.9</td></tr><tr><td align="left" rowspan="2" colspan="1">VO<sub>2</sub>, mL/min/kg</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">3.70 &#x000b1; 0.72</td><td align="center" rowspan="1" colspan="1">3.90 &#x000b1; 0.72</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">8.77 &#x000b1; 1.39</td><td align="center" rowspan="1" colspan="1">9.10 &#x000b1; 2.51</td></tr><tr><td align="left" rowspan="2" colspan="1">VCO<sub>2</sub>, mL/min/kg</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">3.64 &#x000b1; 0.52</td><td align="center" rowspan="1" colspan="1">3.60 &#x000b1; 0.74</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">8.14 &#x000b1; 1.86</td><td align="center" rowspan="1" colspan="1">8.90 &#x000b1; 2.09</td></tr></tbody></table><table-wrap-foot><p>Results are presented as the mean &#x000b1; SD or %, unless otherwise indicated.
ETCO<sub>2</sub>: end tidal CO<sub>2</sub>; PESE: phasic electrical stimulation
during expiration; RR: respiratory rate; SpO<sub>2</sub>: percutaneous oxygen
saturation; Te: expiratory time; Ti: inspiratory time; Ttot: total respiratory time;
TV: tidal volume; VD/VT: dead-space gas volume to tidal gas volume; VE: minute
ventilation; VO<sub>2</sub>: oxygen uptake; VCO<sub>2</sub>: carbon dioxide output</p></table-wrap-foot></table-wrap> shows the results of statistical comparisons of the main parameters between
the two groups. No significant differences were observed between the groups for ventilation
index, respiratory time index, ventilation pattern index, dyspnea, or SpO<sub>2</sub>
baseline data.</p><p><xref rid="tbl_003" ref-type="table">Table 3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Placebo group versus PESE group in COPD patients</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="3" align="left"/><th colspan="2" align="center" rowspan="1">Placebo group (n = 11)</th><th colspan="2" align="center" rowspan="1">PESE group (n = 12)</th></tr><tr><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">Sham</th><th align="center" rowspan="1" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">PESE</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">VE, mL/min</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">10.5 &#x000b1; 2.8</td><td align="center" rowspan="1" colspan="1">11.1 &#x000b1; 2.54</td><td align="center" rowspan="1" colspan="1">10.2 &#x000b1; 1.6</td><td align="center" rowspan="1" colspan="1">10.1 &#x000b1; 1.57</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">20.2 &#x000b1; 5.1</td><td align="center" rowspan="1" colspan="1">21.3 &#x000b1; 5.22</td><td align="center" rowspan="1" colspan="1">19.9 &#x000b1; 4.4</td><td align="center" rowspan="1" colspan="1">21.3 &#x000b1; 6.1</td></tr><tr><td align="left" rowspan="2" colspan="1">TV, mL</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">799.0 &#x000b1; 321.0</td><td align="center" rowspan="1" colspan="1">894.0 &#x000b1; 392.0</td><td align="center" rowspan="1" colspan="1">730.0 &#x000b1; 172.0</td><td align="center" rowspan="1" colspan="1">1,100.0 &#x000b1; 316.0**</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">1,085.0 &#x000b1; 354.0</td><td align="center" rowspan="1" colspan="1">1,237.0 &#x000b1; 459.0</td><td align="center" rowspan="1" colspan="1">1,104.0 &#x000b1; 262.0</td><td align="center" rowspan="1" colspan="1">1,403.0 &#x000b1; 422.0*</td></tr><tr><td align="left" rowspan="2" colspan="1">RR, n/min</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">16.1 &#x000b1; 4.22</td><td align="center" rowspan="1" colspan="1">14.1 &#x000b1; 4.62</td><td align="center" rowspan="1" colspan="1">16.0 &#x000b1; 3.28</td><td align="center" rowspan="1" colspan="1">10.2 &#x000b1; 3.84**</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">21.6 &#x000b1; 4.6</td><td align="center" rowspan="1" colspan="1">19.3 &#x000b1; 6.6</td><td align="center" rowspan="1" colspan="1">20.2 &#x000b1; 4.6</td><td align="center" rowspan="1" colspan="1">16.9 &#x000b1; 6.95*</td></tr><tr><td align="left" rowspan="2" colspan="1">Te, s</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">2.75 &#x000b1; 1.50</td><td align="center" rowspan="1" colspan="1">3.28 &#x000b1; 2.43</td><td align="center" rowspan="1" colspan="1">2.43 &#x000b1; 0.66</td><td align="center" rowspan="1" colspan="1">3.94 &#x000b1; 1.39**</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">1.91 &#x000b1; 0.74</td><td align="center" rowspan="1" colspan="1">2.24 &#x000b1;1.01</td><td align="center" rowspan="1" colspan="1">1.92 &#x000b1; 0.58</td><td align="center" rowspan="1" colspan="1">2.59 &#x000b1; 1.24*</td></tr><tr><td align="left" rowspan="2" colspan="1">Ttot, s</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">4.21 &#x000b1; 1.91</td><td align="center" rowspan="1" colspan="1">4.86 &#x000b1; 3.16</td><td align="center" rowspan="1" colspan="1">3.99 &#x000b1; 1.07</td><td align="center" rowspan="1" colspan="1">6.64 &#x000b1; 1.84**</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">3.04 &#x000b1; 1.04</td><td align="center" rowspan="1" colspan="1">3.69 &#x000b1; 1.72</td><td align="center" rowspan="1" colspan="1">3.13 &#x000b1; 0.70</td><td align="center" rowspan="1" colspan="1">4.21 &#x000b1; 1.67*</td></tr><tr><td align="left" rowspan="2" colspan="1">VD/VT</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">0.43 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">0.41 &#x000b1; 0.08</td><td align="center" rowspan="1" colspan="1">0.42 &#x000b1; 0.05</td><td align="center" rowspan="1" colspan="1">0.37 &#x000b1; 0.03**</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">0.40 &#x000b1; 0.05</td><td align="center" rowspan="1" colspan="1">0.38 &#x000b1; 0.06**</td><td align="center" rowspan="1" colspan="1">0.37 &#x000b1; 0.04</td><td align="center" rowspan="1" colspan="1">0.35 &#x000b1; 0.04*</td></tr><tr><td align="left" rowspan="2" colspan="1">ETCO<sub>2</sub>, %</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">4.43 &#x000b1; 0.75</td><td align="center" rowspan="1" colspan="1">4.44 &#x000b1; 0.81</td><td align="center" rowspan="1" colspan="1">4.35 &#x000b1; 0.33</td><td align="center" rowspan="1" colspan="1">4.44 &#x000b1; 0.59</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">5.08 &#x000b1; 0.87</td><td align="center" rowspan="1" colspan="1">5.01 &#x000b1; 0.80</td><td align="center" rowspan="1" colspan="1">4.89 &#x000b1; 0.53</td><td align="center" rowspan="1" colspan="1">4.99 &#x000b1; 0.69</td></tr><tr><td align="left" rowspan="2" colspan="1">Borg dyspnea, points</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">0.04 &#x000b1; 0.15</td><td align="center" rowspan="1" colspan="1">0.13 &#x000b1; 0.32</td><td align="center" rowspan="1" colspan="1">0.16 &#x000b1; 0.57</td><td align="center" rowspan="1" colspan="1">0.60 &#x000b1; 1.06</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">1.45 &#x000b1; 0.16</td><td align="center" rowspan="1" colspan="1">1.36 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">1.54 &#x000b1; 1.52</td><td align="center" rowspan="1" colspan="1">1.54 &#x000b1; 1.40</td></tr><tr><td align="left" rowspan="2" colspan="1">SpO<sub>2</sub>, %</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">95.9 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">96.1 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">96.0 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">95.9 &#x000b1; 2.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">92.5 &#x000b1; 4.0</td><td align="center" rowspan="1" colspan="1">93.4 &#x000b1; 4.2</td><td align="center" rowspan="1" colspan="1">93.8 &#x000b1; 2.9</td><td align="center" rowspan="1" colspan="1">93.7 &#x000b1; 2.8</td></tr><tr><td align="left" rowspan="2" colspan="1">VO<sub>2</sub>, mL/min/kg</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">3.70 &#x000b1; 0.72</td><td align="center" rowspan="1" colspan="1">3.69 &#x000b1; 0.30</td><td align="center" rowspan="1" colspan="1">3.90 &#x000b1; 0.72</td><td align="center" rowspan="1" colspan="1">4.00 &#x000b1; 0.79</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">8.77 &#x000b1; 1.39</td><td align="center" rowspan="1" colspan="1">8.77 &#x000b1; 1.68</td><td align="center" rowspan="1" colspan="1">9.10 &#x000b1; 2.51</td><td align="center" rowspan="1" colspan="1">10.05 &#x000b1; 2.24</td></tr><tr><td align="left" rowspan="2" colspan="1">VCO<sub>2</sub>, mL/min/kg</td><td align="left" rowspan="1" colspan="1">Rest</td><td align="center" rowspan="1" colspan="1">3.64 &#x000b1; 0.52</td><td align="center" rowspan="1" colspan="1">4.04 &#x000b1; 1.91</td><td align="center" rowspan="1" colspan="1">3.60 &#x000b1; 0.74</td><td align="center" rowspan="1" colspan="1">3.65 &#x000b1; 0.82</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise</td><td align="center" rowspan="1" colspan="1">8.14 &#x000b1; 1.86</td><td align="center" rowspan="1" colspan="1">8.48 &#x000b1; 1.75</td><td align="center" rowspan="1" colspan="1">8.90 &#x000b1; 2.09</td><td align="center" rowspan="1" colspan="1">8.97 &#x000b1; 2.49</td></tr></tbody></table><table-wrap-foot><p>Results are presented as the mean &#x000b1; SD or %, unless otherwise indicated.
ETCO<sub>2</sub>: end tidal CO<sub>2</sub>; PESE: phasic electrical stimulation
during expiration; RR: respiratory rate; SpO<sub>2</sub>: percutaneous oxygen
saturation; Te: expiratory time; Ti: inspiratory time; Ttot: total respiratory time;
TV: tidal volume; VD/VT: dead-space gas volume to tidal gas volume; VE: minute
ventilation; VO<sub>2</sub>: oxygen uptake; VCO<sub>2</sub>: carbon dioxide output.
*p&#x0003c;0.05, **p&#x0003c;0.01</p></table-wrap-foot></table-wrap> shows comparisons for each measurement parameter before and during exercise.
No significant difference was demonstrated for VE in either group. No significant difference
was observed for TV in the placebo group, but a significant increase was observed in the
PESE group, both at rest and during exercise (rest, p = 0.002; exercise, p = 0.015). No
significant difference was observed for RR in the placebo group, but a significant decrease
was observed in the PESE group, both at rest and during exercise (rest, p = 0.007; exercise,
p = 0.028). No significant difference was observed for Te in the placebo group, but a
significant prolongation was observed in the PESE group, both at rest and during exercise
(rest, p = 0.009; exercise, p = 0.049). A significant decrease in VD/VT was observed in the
placebo group during exercise (p = 0.003) and in the PESE group both at rest and during
exercise (rest, p = 0.006; exercise, p = 0.022). No significant differences were observed
for VO<sub>2</sub>, VCO<sub>2</sub>, Borg scale, or SpO<sub>2</sub> in either group.</p></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>The purpose of this study was to determine the effect of ventilation feedback provided by
electrical stimulation on ventilatory function during exercise in patients with COPD. The
results of this study revealed two new findings. The first was that PESE improves the
ventilation pattern in patients with COPD both at rest and during exercise. The second
finding was that oxygen uptake does not increase with PESE.</p><p>Consistent with previous studies, we believe the PESE ventilation pattern improvement
resulted from a properly functioning biofeedback (BF) mechanism<xref rid="r10" ref-type="bibr">10</xref>, <xref rid="r11" ref-type="bibr">11</xref><sup>)</sup>. Providing
feedback through skin receptors with PESE on expiration both at rest and during exercise may
have improved the ventilation pattern by enhancing awareness of prolonged expirations.</p><p>While it became clear that the ventilation pattern was improved with PESE, no change was
observed in breathlessness (Borg scale) or SpO<sub>2</sub>. It is common for SpO<sub>2</sub>
to not improve despite a patient&#x02019;s ventilatory function improving in clinical settings
through drug and oxygen therapy. This may be related to the difficulty in finding a
permanent cure for the pathogenesis of bronchial and lung parenchyma damage in COPD and the
presence of complex structures damaged by desaturation<xref rid="r20" ref-type="bibr">20</xref><sup>)</sup>.</p><p>The Borg scale, which increases with the exercise load, may not have improved in the PESE
group because dynamic hyperinflation was not reproduced by the short, low-intensity exercise
performed in this study. Furthermore, dyspnea during exercise may have been affected by
hyperventilation associated with exercise and accompanying fatigue of respiratory muscles,
although this kind of reaction could not be reproduced with short, low-intensity exercise.
These effects also could result from small variations in VO<sub>2</sub> when exercise is
commenced after resting.</p><p>Next, we will discuss why PESE had no effect on SpO<sub>2</sub>. SpO<sub>2</sub> is a
parameter that shows the state of oxygenation, and its association with PaO<sub>2</sub> is
well known. Therefore, we will proceed with this discussion by substituting PaO<sub>2</sub>
for SpO<sub>2.</sub></p><p>PaO<sub>2</sub> is calculated with the following formula:<disp-formula>PaO<sub>2</sub>=
713 &#x000d7; FIO<sub>2</sub> &#x02212; K &#x000d7; VO<sub>2</sub>/VE (1&#x02212;VD/VT) &#x02212;
A-aDO<sub>2</sub>,</disp-formula>where PaO<sub>2</sub> is the partial pressure
of arterial oxygen, FIO<sub>2</sub> is the fraction of inspired oxygen, K is a constant
(0.863), VO<sub>2</sub> is the oxygen uptake, VE is the minute ventilation, VD/VT is the
dead-space gas volume to tidal gas volume, and A<bold>-</bold>aDO<sub>2</sub> is the
difference in alveolar arterial oxygen partial pressure.</p><p>During the present experiment, FIO<sub>2</sub> was kept constant, and because no
pathologies such as retention of sputum, pneumonia, or pleural effusion were observed in
A-aDO<sub>2</sub>, it is unlikely that changes occurred during the experiment. Therefore,
the parameters that should be considered as factors determining PaO<sub>2</sub> in this
experiment are VO<sub>2</sub>, VE, and VD/VT. Focusing on these individual parameters, it is
clear that VE is not affected by PESE, remaining in the same steady state as before the
intervention. While VD/VT showed a statistically significant decline, the actual variation
was very small and likely did not affect PaO<sub>2</sub>. We believe that the observed lack
of change in the study parameters after PESE was because PaO<sub>2</sub> was unchanged, and
these results were reflected in the SpO<sub>2</sub> values. We will discuss VO<sub>2</sub>
in detail in the next section.</p><p>Muscle metabolism decreases in patients with COPD<xref rid="r21" ref-type="bibr">21</xref><sup>)</sup>. Encouraging unnecessary muscle contractions in patients with COPD
promotes anaerobic metabolism, causes acidosis resulting from lactic acid accumulation, and
stimulates the respiratory center, thereby enhancing ventilation. This process may increase
respiratory muscle work and exacerbate dyspnea. It needs to be confirmed whether PESE itself
triggered the above effects or if they were triggered by voluntary muscle contractions from
BF. Thus, it is extremely important to consider the effects of PESE on VO<sub>2</sub>.</p><p>Below is the Fick equation including the VO<sub>2</sub> calculation and its relevant
formula:<disp-formula>VO<sub>2</sub> = Q (CaO<sub>2</sub> &#x02212;
CvO<sub>2</sub>),</disp-formula>where Q is the cardiac output, CaO<sub>2</sub>
is the arterial oxygen content, and CvO<sub>2</sub> is the venous oxygen
content.<disp-formula>CaO<sub>2</sub> = 1.34 &#x000d7; Hb [g/dL] &#x000d7; SaO<sub>2</sub> [%]/100 +
0.003 &#x000d7; PaO<sub>2</sub>[mmHg]</disp-formula>, where CaO<sub>2</sub> is the arterial oxygen
content, Hb is the venous oxygen content, and SaO<sub>2</sub> is the O<sub>2</sub>
saturation.</p><p>From these two formulas, we can see that the determinants of VO<sub>2</sub> are Hb,
SaO<sub>2</sub>, PaO<sub>2</sub>, and CvO<sub>2</sub>. In the present study, the PESE
intervention resulted in no significant increase in VO<sub>2</sub>. Although
SpO<sub>2</sub>, which was measured in place of SaO<sub>2</sub>, decreased with exercise, no
specific effect of PESE was observed during rest or exercise. The majority of
CaO<sub>2</sub> is not dissolved oxygen in the blood; the CaO<sub>2</sub> shown in the
Fick equation is considered unchanged because it is hemoglobin-bound oxygen, as demonstrated
by SpO<sub>2</sub>. Considering the fact that VO<sub>2</sub> does not change during exercise
with PESE, it appears unlikely that PESE increases cardiac output (Q). Furthermore, if we
assume that CaO<sub>2</sub> does not change for the aforementioned reasons, CvO<sub>2</sub>
also will remain unchanged. This implies that PESE did not induce muscle contractions that
could increase VO<sub>2</sub>. This is clear from the fact that VCO<sub>2</sub> did not
increase during exercise with PESE.</p><p>One limitation of this study was the inability to investigate exercise intensity and
duration from the perspective of practicality. Breathlessness in patients with COPD is
significant not only during walking, but also during activities such as climbing stairs. The
continuation of such activities is often accompanied by muscle fatigue and enhanced
ventilation associated with lactate accumulation<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>. Therefore, considering these facts, studies based on exercise
intensity and duration are extremely important with regard to practical PESE applications.
Another limitation of this study was that dynamic hyperinflation and muscle metabolism
assessments could not be performed.</p><p>Finally, COPD, which has an increasing incidence in the population, has a high prevalence
in the elderly<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>, and the relationship
between COPD and decreased cognitive function has been recently reported<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr">24</xref><sup>)</sup>. The development of new rehabilitation
methods is urgently needed to delay the progression of cognitive impairment in patients with
COPD.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Ries</surname><given-names>AL</given-names></name><name><surname>Bauldoff</surname><given-names>GS</given-names></name><name><surname>Carlin</surname><given-names>BW</given-names></name><etal>et al.</etal></person-group>: <article-title>Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based
clinical practice guidelines</article-title>. <source>Chest</source>, <year>2007</year>,
<volume>131</volume>: <fpage>4S</fpage>&#x02013;<lpage>42S</lpage>. <pub-id pub-id-type="pmid">17494825</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Ries</surname><given-names>AL</given-names></name><name><surname>Kaplan</surname><given-names>RM</given-names></name><name><surname>Limberg</surname><given-names>TM</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of pulmonary rehabilitation on physiologic and
psychosocial outcomes in patients with chronic obstructive pulmonary
disease</article-title>. <source>Ann Intern Med</source>, <year>1995</year>,
<volume>122</volume>: <fpage>823</fpage>&#x02013;<lpage>832</lpage>. <pub-id pub-id-type="pmid">7741366</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Vestbo</surname><given-names>J</given-names></name><name><surname>Hurd</surname><given-names>SS</given-names></name><name><surname>Agust&#x000ed;</surname><given-names>AG</given-names></name><etal>et al.</etal></person-group>: <article-title>Global strategy for the diagnosis, management, and
prevention of chronic obstructive pulmonary disease: GOLD executive
summary</article-title>. <source>Am J Respir Crit Care Med</source>, <year>2013</year>,
<volume>187</volume>: <fpage>347</fpage>&#x02013;<lpage>365</lpage>. <pub-id pub-id-type="pmid">22878278</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Uchiyama</surname><given-names>K</given-names></name><name><surname>Miaki</surname><given-names>H</given-names></name><name><surname>Terada</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>Effect of muscle strength training and muscle endurance
training on muscle deoxygenation level and endurance performance</article-title>.
<source>J Phys Ther Sci</source>, <year>2011</year>, <volume>23</volume>:
<fpage>349</fpage>&#x02013;<lpage>355</lpage>. </mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Chigira</surname><given-names>Y</given-names></name><name><surname>Takai</surname><given-names>T</given-names></name><name><surname>Oda</surname><given-names>T</given-names></name><etal>et al</etal></person-group><article-title>.: Difference in the effect of outpatient pulmonary
rehabilitation due to variation in the intervention frequency: intervention centering on
home-based exercise</article-title>. <source>J Phys Ther Sci</source>,
<year>2014</year>, <volume>26</volume>: <fpage>1041</fpage>&#x02013;<lpage>1044</lpage>.
<pub-id pub-id-type="pmid">25140092</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Fukuchi</surname><given-names>Y</given-names></name><name><surname>Nishimura</surname><given-names>M</given-names></name><name><surname>Ichinose</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>COPD in Japan: the Nippon COPD Epidemiology
study</article-title>. <source>Respirology</source>, <year>2004</year>,
<volume>9</volume>: <fpage>458</fpage>&#x02013;<lpage>465</lpage>. <pub-id pub-id-type="pmid">15612956</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Murray</surname><given-names>CJ</given-names></name><name><surname>Lopez</surname><given-names>AD</given-names></name></person-group>: <article-title>Evidence-based health policy&#x02014;lessons from the Global
Burden of Disease Study</article-title>. <source>Science</source>, <year>1996</year>,
<volume>274</volume>: <fpage>740</fpage>&#x02013;<lpage>743</lpage>. <pub-id pub-id-type="pmid">8966556</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Rabe</surname><given-names>KF</given-names></name><name><surname>Hurd</surname><given-names>S</given-names></name><name><surname>Anzueto</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>Global Initiative for Chronic Obstructive Lung Disease:
<article-title>Global strategy for the diagnosis, management, and prevention of chronic
obstructive pulmonary disease: GOLD executive summary</article-title>. <source>Am J
Respir Crit Care Med</source>, <year>2007</year>, <volume>176</volume>:
<fpage>532</fpage>&#x02013;<lpage>555</lpage>. <pub-id pub-id-type="pmid">17507545</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Casaburi</surname><given-names>R</given-names></name><name><surname>Patessio</surname><given-names>A</given-names></name><name><surname>Ioli</surname><given-names>F</given-names></name><etal>et al.</etal></person-group>: <article-title>Reductions in exercise lactic acidosis and ventilation as
a result of exercise training in patients with obstructive lung disease</article-title>.
<source>Am Rev Respir Dis</source>, <year>1991</year>, <volume>143</volume>:
<fpage>9</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="pmid">1986689</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Bianchi</surname><given-names>R</given-names></name><name><surname>Gigliotti</surname><given-names>F</given-names></name><name><surname>Romagnoli</surname><given-names>I</given-names></name><etal>et al.</etal></person-group>: <article-title>Chest wall kinematics and breathlessness during pursed-lip
breathing in patients with COPD</article-title>. <source>Chest</source>,
<year>2004</year>, <volume>125</volume>: <fpage>459</fpage>&#x02013;<lpage>465</lpage>.
<pub-id pub-id-type="pmid">14769725</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Ingram</surname><given-names>RH</given-names><suffix>Jr</suffix></name><name><surname>Schilder</surname><given-names>DP</given-names></name></person-group>: <article-title>Effect of pursed lips expiration on the pulmonary
pressure-flow relationship in obstructive lung disease</article-title>. <source>Am Rev
Respir Dis</source>, <year>1967</year>, <volume>96</volume>:
<fpage>381</fpage>&#x02013;<lpage>388</lpage>. <pub-id pub-id-type="pmid">6039092</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Collins</surname><given-names>EG</given-names></name><name><surname>Fehr</surname><given-names>L</given-names></name><name><surname>Bammert</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>Effect of ventilation-feedback training on endurance and
perceived breathlessness during constant work-rate leg-cycle exercise in patients with
COPD</article-title>. <source>J Rehabil Res Dev</source>, <year>2003</year>,
<volume>40</volume>: <fpage>35</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="pmid">15074452</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Collins</surname><given-names>EG</given-names></name><name><surname>Langbein</surname><given-names>WE</given-names></name><name><surname>Fehr</surname><given-names>L</given-names></name><etal>et al.</etal></person-group>: <article-title>Can ventilation-feedback training augment exercise
tolerance in patients with chronic obstructive pulmonary
disease?</article-title><source>Am J Respir Crit Care Med</source>, <year>2008</year>,
<volume>177</volume>: <fpage>844</fpage>&#x02013;<lpage>852</lpage>. <pub-id pub-id-type="pmid">18202351</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Kita</surname><given-names>K</given-names></name><name><surname>Otaka</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><etal>et al.</etal></person-group>: <article-title>A pilot study of sensory feedback by transcutaneous
electrical nerve stimulation to improve manipulation deficit caused by severe sensory
loss after stroke</article-title>. <source>J Neuroeng Rehabil</source>,
<year>2013</year>, <volume>10</volume>: <fpage>55</fpage>. <pub-id pub-id-type="pmid">23764012</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Sillen</surname><given-names>MJ</given-names></name><name><surname>Speksnijder</surname><given-names>CM</given-names></name><name><surname>Eterman</surname><given-names>RM</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of neuromuscular electrical stimulation of muscles
of ambulation in patients with chronic heart failure or COPD: a systematic review of the
English-language literature</article-title>. <source>Chest</source>, <year>2009</year>,
<volume>136</volume>: <fpage>44</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="pmid">19363213</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Gerovasili</surname><given-names>V</given-names></name><name><surname>Stefanidis</surname><given-names>K</given-names></name><name><surname>Vitzilaios</surname><given-names>K</given-names></name><etal>et al.</etal></person-group>: <article-title>Electrical muscle stimulation preserves the muscle mass of
critically ill patients: a randomized study</article-title>. <source>Crit Care</source>,
<year>2009</year>, <volume>13</volume>: <fpage>R161</fpage>. <pub-id pub-id-type="pmid">19814793</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Vivodtzev</surname><given-names>I</given-names></name><name><surname>Lacasse</surname><given-names>Y</given-names></name><name><surname>Maltais</surname><given-names>F</given-names></name></person-group>: <article-title>Neuromuscular electrical stimulation of the lower limbs in
patients with chronic obstructive pulmonary disease</article-title>. <source>J
Cardiopulm Rehabil Prev</source>, <year>2008</year>, <volume>28</volume>:
<fpage>79</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="pmid">18360183</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Vivodtzev</surname><given-names>I</given-names></name><name><surname>P&#x000e9;pin</surname><given-names>JL</given-names></name><name><surname>Vottero</surname><given-names>G</given-names></name><etal>et al.</etal></person-group>: <article-title>Improvement in quadriceps strength and dyspnea in daily
tasks after 1 month of electrical stimulation in severely deconditioned and malnourished
COPD</article-title>. <source>Chest</source>, <year>2006</year>, <volume>129</volume>:
<fpage>1540</fpage>&#x02013;<lpage>1548</lpage>. <pub-id pub-id-type="pmid">16778272</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Zanotti</surname><given-names>E</given-names></name><name><surname>Felicetti</surname><given-names>G</given-names></name><name><surname>Maini</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>Peripheral muscle strength training in bed-bound patients
with COPD receiving mechanical ventilation: effect of electrical
stimulation</article-title>. <source>Chest</source>, <year>2003</year>,
<volume>124</volume>: <fpage>292</fpage>&#x02013;<lpage>296</lpage>. <pub-id pub-id-type="pmid">12853536</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Neder</surname><given-names>JA</given-names></name><name><surname>Sword</surname><given-names>D</given-names></name><name><surname>Ward</surname><given-names>SA</given-names></name><etal>et al.</etal></person-group>: <article-title>Home based neuromuscular electrical stimulation as a new
rehabilitative strategy for severely disabled patients with chronic obstructive
pulmonary disease (COPD)</article-title>. <source>Thorax</source>, <year>2002</year>,
<volume>57</volume>: <fpage>333</fpage>&#x02013;<lpage>337</lpage>. <pub-id pub-id-type="pmid">11923552</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Bourjeily-Habr</surname><given-names>G</given-names></name><name><surname>Rochester</surname><given-names>CL</given-names></name><name><surname>Palermo</surname><given-names>F</given-names></name><etal>et al.</etal></person-group>: <article-title>Randomised controlled trial of transcutaneous electrical
muscle stimulation of the lower extremities in patients with chronic obstructive
pulmonary disease</article-title>. <source>Thorax</source>, <year>2002</year>,
<volume>57</volume>: <fpage>1045</fpage>&#x02013;<lpage>1049</lpage>. <pub-id pub-id-type="pmid">12454299</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Casaburi</surname><given-names>R</given-names></name><name><surname>ZuWallack</surname><given-names>R</given-names></name></person-group>: <article-title>Pulmonary rehabilitation for management of chronic
obstructive pulmonary disease</article-title>. <source>N Engl J Med</source>,
<year>2009</year>, <volume>360</volume>: <fpage>1329</fpage>&#x02013;<lpage>1335</lpage>.
<pub-id pub-id-type="pmid">19321869</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Wouters</surname><given-names>EF</given-names></name></person-group>: <article-title>Chronic obstructive pulmonary disease. 5: systemic effects
of COPD</article-title>. <source>Thorax</source>, <year>2002</year>,
<volume>57</volume>: <fpage>1067</fpage>&#x02013;<lpage>1070</lpage>. <pub-id pub-id-type="pmid">12454303</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Schou</surname><given-names>L</given-names></name><name><surname>&#x000d8;stergaard</surname><given-names>B</given-names></name><name><surname>Rasmussen</surname><given-names>LS</given-names></name><etal>et al.</etal></person-group>: <article-title>Cognitive dysfunction in patients with chronic obstructive
pulmonary disease&#x02014;a systematic review</article-title>. <source>Respir Med</source>,
<year>2012</year>, <volume>106</volume>: <fpage>1071</fpage>&#x02013;<lpage>1081</lpage>.
<pub-id pub-id-type="pmid">22579108</pub-id></mixed-citation></ref></ref-list></back></article>